Medical Journals

Structural Determinants of Salmon Calcitonin Bioactivity: the Role of the Leu-based Amphipathic Alpha-helix.

Authors:
  • Andreotti Giuseppina
  • Méndez Blanca López
  • Amodeo Pietro
  • Morelli Maria A Castiglione
  • Nakamuta Hiromichi
  • Motta Andrea

From: Istituto di Chimica Biomolecolare del Consiglio Nazionale delle Ricerche, Comprensorio Olivetti, Edificio A, 80078 Pozzuoli (Napoli), Italy.

The Journal of biological chemistry

  • Publish Date: Aug 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 34
  • Pages: 24193-203
  • Medium: Print
  • Language: English
  • Citation (JAMA): Andreotti Giuseppina, Méndez Blanca López, Amodeo Pietro, et al. Structural Determinants of Salmon Calcitonin Bioactivity: the Role of the Leu-based Amphipathic Alpha-helix.. J. Biol. Chem. Aug 2006;281:24193-203

Abstract

Salmon calcitonin (sCT) forms an amphipathic helix in the region 9-19, with the C-terminal decapeptide interacting with the helix (Amodeo, P., Motta, A., Strazzullo, G., Castiglione Morelli, M. A.(1999) J. Biomol. NMR 13, 161-174). To uncover the structural requirements for the hormone bioactivity, we investigated several sCT analogs. They were designed so as to alter the length of the central helix by removal and/or replacement of flanking residues and by selectively mutating or deleting residues inside the helix. The helix content was assessed by circular dichroism and NMR spectroscopies; the receptor binding affinity in human breast cancer cell line T 47D and the in vivo hypocalcemic activity were also evaluated. In particular, by NMR spectroscopy and molecular dynamics calculations we studied Leu(23),Ala(24)-sCT in which Pro(23) and Arg(24) were replaced by helix inducing residues. Compared with sCT, it assumes a longer amphipathic alpha-helix, with decreased binding affinity and one-fifth of the hypocalcemic activity, therefore supporting the idea of a relationship between a definite helix length and bioactivity. From the analysis of other sCT mutants, we inferred that the correct helix length is located in the 9-19 region and requires long range interactions and the presence of specific regions of residues within the sequence for high binding affinity and hypocalcemic activity. Taken together, the structural and biological data identify well defined structural parameters of the helix for sCT bioactivity.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Binding Sites, Calcitonin, Cell Line, Tumor, Circular Dichroism, Female, Humans, Magnetic Resonance Spectroscopy, Models, Molecular, Molecular Sequence Data, Mutation, Protein Binding, Protein Conformation, Receptors, Calcitonin, Salmon, Sequence Analysis, Structure-Activity Relationship


Check for Full Text / PubMed Unique Identifier (PMID): 16766525


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.